Maraviroc treatment in non-R5-HIV-1-infected patients results in the selection of extreme CXCR4-using variants with limited effect on the total viral setpoint. (Q50990539)
Jump to navigation
Jump to search
scientific article published on 14 May 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Maraviroc treatment in non-R5-HIV-1-infected patients results in the selection of extreme CXCR4-using variants with limited effect on the total viral setpoint. |
scientific article published on 14 May 2013 |
Statements
Maraviroc treatment in non-R5-HIV-1-infected patients results in the selection of extreme CXCR4-using variants with limited effect on the total viral setpoint (English)
Rachel A McGovern
P Richard Harrigan
Steven F L van Lelyveld
Andy I M Hoepelman
Petra M van Ham
Winnie Dong
Annemarie M J Wensing